Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD28/B7 system of T cell costimulation

D J Lenschow1, T L Walunas, J A Bluestone

  • 1Committee on Immunology, Ben May Institute, Chicago, Illinois 60637, USA.

Annual Review of Immunology
|January 1, 1996
PubMed
Summary

The CD28/B7 pathway is crucial for T cell activation and immune regulation. Understanding its complex interactions is key to developing new therapies for immune suppression and tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Extra-Islet Pancreas Supports Autoimmunity in Human Type 1 Diabetes.

medRxiv : the preprint server for health sciences·2023
Same author

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Cell-surface molecules involved in T-cell functions.

Immunology today·2014
Same author

The regulation of the immune system.

Immunology today·2014
Same author

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.

Diabetologia·2012

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • T cells are central to immune responses, requiring TCR engagement and co-stimulatory signals for activation.
  • The CD28/B7 receptor/ligand system is a dominant co-stimulatory pathway influencing T cell responses.
  • Interruption of CD28/B7 signaling can suppress immune responses or induce antigen-specific tolerance.

Purpose of the Study:

  • To review the current understanding of CD28/B7 immunobiology.
  • To summarize experimental findings on CD28/B7 pathway participants.
  • To illustrate models of CD28/B7-mediated T and B cell regulation.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of experimental data on CD28/B7 interactions.
  • Synthesis of current models of immune cell regulation.

Main Results:

  • The CD28/B7 system involves multiple receptors and ligands with diverse signaling roles.
  • CD28/B7 interactions are critical for both T cell activation and regulation.
  • Complexities in the CD28/B7 system necessitate further research.

Conclusions:

  • The CD28/B7 pathway's complexity impacts immune responses and therapeutic strategies.
  • Further research is needed to fully elucidate the CD28/B7 signaling pathway.
  • Understanding this pathway can lead to novel approaches for immune modulation.

Related Experiment Videos